A carregar...
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 798.51 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Concomitant occurrence of acute myocardial infarction (MI)
and stroke is infrequently encountered in emergent patients.
Acute MI within the previous 3 months is considered a relative
contraindication for therapy with alteplase or intravenous tissue
plasminogen activator (IV rtPA).1
The use of IV rtPA for stroke
in patients with a recent MI is associated with an increased risk
of cardiac rupture, secondary to breakdown of the existing fibrin
clot within the necrotic myocardium and/or degradation of collagen2
. Whether it is appropriate to perform thrombolysis in an
emergent patient with concomitant ischemic stroke and MI remains a matter for debate.
Descrição
Palavras-chave
Cardiac rupture Therapy
Contexto Educativo
Citação
Editora
Korean Stroke Society